Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 May;80(5):429–434. doi: 10.1136/bjo.80.5.429

An elevated level of copper zinc superoxide dismutase fails to prevent oxygen induced retinopathy in mice.

C Klaeger 1, L de Sa 1, A J Klaeger 1, E J Carlson 1, W V Good 1, C J Epstein 1
PMCID: PMC505495  PMID: 8695565

Abstract

BACKGROUND: To determine whether a higher level of copper zinc superoxide dismutase (CuZnSOD) can reduce the severity of oxygen induced retinopathy (OIR) in a mouse model. METHODS: CuZnSOD transgenic mice with a threefold increase in CuZnSOD activity and control non-transgenic mice were exposed to 90% oxygen for 12 hours a day during the first 5 days of life. After oxygen treatment, all mice were reared in room air for 10 days. Another group of transgenic and non-transgenic mice were kept in room air for 15 days and served as control groups for the oxygen effect. At day 15, all mice were killed and perfused with India ink. The retinas were flat mounted on slides and examined with a light microscope. RESULTS: There was a statistically significant increase in the incidence of OIR in mice exposed to high levels of oxygen, whether or not they were transgenic. However, there was no statistically significant difference in the severity of OIR between oxygen treated transgenic and non-transgenic mice. CONCLUSION: A threefold higher CuZnSOD activity does not protect against OIR in mice. This is an unexpected finding, since oxygen radicals are considered a major factor causing OIR, and increased CuZnSOD activity has reduced oxygen radical induced damage in several neuronal and non-neuronal systems. The possibility of a damaging role for other radicals not affected by CuZnSOD cannot be excluded.

Full text

PDF
429

Images in this article

430Image
on p.430
431Image
on p.431
431Image
on p.431

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton N. Donders lecture, 1967. Some aspecrs of the comparative pathology of oxygen toxicity in the retina. Br J Ophthalmol. 1968 Jul;52(7):505–531. [PubMed] [Google Scholar]
  2. Bancalari E., Flynn J., Goldberg R. N., Bawol R., Cassady J., Schiffman J., Feuer W., Roberts J., Gillings D., Sim E. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics. 1987 May;79(5):663–669. [PubMed] [Google Scholar]
  3. Boynton B. R., Boynton C. A. Retinopathy of prematurity and bilirubin. N Engl J Med. 1989 Jul 20;321(3):193–194. doi: 10.1056/nejm198907203210317. [DOI] [PubMed] [Google Scholar]
  4. Cadet J. L., Sheng P., Ali S., Rothman R., Carlson E., Epstein C. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem. 1994 Jan;62(1):380–383. doi: 10.1046/j.1471-4159.1994.62010380.x. [DOI] [PubMed] [Google Scholar]
  5. Chan P. H., Yang G. Y., Chen S. F., Carlson E., Epstein C. J. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase. Ann Neurol. 1991 May;29(5):482–486. doi: 10.1002/ana.410290506. [DOI] [PubMed] [Google Scholar]
  6. Connolly S. E., Hores T. A., Smith L. E., D'Amore P. A. Characterization of vascular development in the mouse retina. Microvasc Res. 1988 Nov;36(3):275–290. doi: 10.1016/0026-2862(88)90028-3. [DOI] [PubMed] [Google Scholar]
  7. Epstein C. J., Avraham K. B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8044–8048. doi: 10.1073/pnas.84.22.8044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fauchère J. C., Meier-Gibbons F. E., Koerner F., Bossi E. Retinopathy of prematurity and bilirubin--no clinical evidence for a beneficial role of bilirubin as a physiological anti-oxidant. Eur J Pediatr. 1994 May;153(5):358–362. doi: 10.1007/BF01956419. [DOI] [PubMed] [Google Scholar]
  9. Feeney L., Berman E. R. Oxygen toxicity: membrane damage by free radicals. Invest Ophthalmol. 1976 Oct;15(10):789–792. [PubMed] [Google Scholar]
  10. Flynn J. T. Acute proliferative retrolental fibroplasia: multivariate risk analysis. Trans Am Ophthalmol Soc. 1983;81:549–591. [PMC free article] [PubMed] [Google Scholar]
  11. Flynn J. T., Bancalari E., Snyder E. S., Goldberg R. N., Feuer W., Cassady J., Schiffman J., Feldman H. I., Bachynski B., Buckley E. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med. 1992 Apr 16;326(16):1050–1054. doi: 10.1056/NEJM199204163261603. [DOI] [PubMed] [Google Scholar]
  12. Flynn J. T. Retinopathy of prematurity. Pediatr Clin North Am. 1987 Dec;34(6):1487–1516. doi: 10.1016/s0031-3955(16)36370-2. [DOI] [PubMed] [Google Scholar]
  13. GERSCHMAN R., NADIG P. W., SNELL A. C., Jr, NYE S. W. Effect of high oxygen concentrations on eyes of newborn mice. Am J Physiol. 1954 Oct;179(1):115–118. doi: 10.1152/ajplegacy.1954.179.1.115. [DOI] [PubMed] [Google Scholar]
  14. GYLLENSTEN L. J., HELLSTROM B. E. Experimental approach to the pathogenesis of retrolental fibroplasia. I. Changes of the eye induced by exposure of newborn mice to concentrated oxygen. Acta Paediatr Suppl. 1954;43(100):131–148. doi: 10.1111/j.1651-2227.1954.tb15463.x. [DOI] [PubMed] [Google Scholar]
  15. Gaton D. D., Gold J., Axer-Siegel R., Wielunsky E., Naor N., Nissenkorn I. Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity. Br J Ophthalmol. 1991 Sep;75(9):532–534. doi: 10.1136/bjo.75.9.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gole G. A., Browning J., Elts S. M. The mouse model of oxygen-induced retinopathy: a suitable animal model for angiogenesis research. Doc Ophthalmol. 1990 Mar;74(3):163–169. doi: 10.1007/BF02482605. [DOI] [PubMed] [Google Scholar]
  17. Heyman E., Ohlsson A., Girschek P. Retinopathy of prematurity and bilirubin. N Engl J Med. 1989 Jan 26;320(4):256–256. doi: 10.1056/NEJM198901263200420. [DOI] [PubMed] [Google Scholar]
  18. KINSEY V. E. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol. 1956 Oct;56(4):481–543. [PubMed] [Google Scholar]
  19. Kinouchi H., Epstein C. J., Mizui T., Carlson E., Chen S. F., Chan P. H. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11158–11162. doi: 10.1073/pnas.88.24.11158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kinsey V. E., Arnold H. J., Kalina R. E., Stern L., Stahlman M., Odell G., Driscoll J. M., Jr, Elliott J. H., Payne J., Patz A. PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics. 1977 Nov;60(5):655–668. [PubMed] [Google Scholar]
  21. Kremer I., Kissun R., Nissenkorn I., Ben-Sira I., Garner A. Oxygen-induced retinopathy in newborn kittens. A model for ischemic vasoproliferative retinopathy. Invest Ophthalmol Vis Sci. 1987 Jan;28(1):126–130. [PubMed] [Google Scholar]
  22. Kubisch H. M., Wang J., Luche R., Carlson E., Bray T. M., Epstein C. J., Phillips J. P. Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9956–9959. doi: 10.1073/pnas.91.21.9956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. MICHAELSON I. C., HERZ N., LEWKOWITZ E., KERTESZ D. Effect of increased oxygen on the development of the retinal vessels; an experimental study. Br J Ophthalmol. 1954 Oct;38(10):577–587. doi: 10.1136/bjo.38.10.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Muller D. P. Vitamin E therapy in retinopathy of prematurity. Eye (Lond) 1992;6(Pt 2):221–225. doi: 10.1038/eye.1992.43. [DOI] [PubMed] [Google Scholar]
  25. PATZ A., EASTHAM A., HIGGINBOTHAM D. H., KLEH T. Oxygen studies in retrolental fibroplasia. II. The production of the microscopic changes of retrolental fibroplasia in experimental animals. Am J Ophthalmol. 1953 Nov;36(11):1511–1522. [PubMed] [Google Scholar]
  26. PATZ A., HOECK L. E., DE LA CRUZ E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol. 1952 Sep;35(9):1248–1253. doi: 10.1016/0002-9394(52)91140-9. [DOI] [PubMed] [Google Scholar]
  27. Penn J. S., Thum L. A., Naash M. I. Oxygen-induced retinopathy in the rat. Vitamins C and E as potential therapies. Invest Ophthalmol Vis Sci. 1992 May;33(6):1836–1845. [PubMed] [Google Scholar]
  28. Phelps D. L. Vitamin E and retrolental fibroplasia in 1982. Pediatrics. 1982 Sep;70(3):420–425. [PubMed] [Google Scholar]
  29. Przedborski S., Kostic V., Jackson-Lewis V., Naini A. B., Simonetti S., Fahn S., Carlson E., Epstein C. J., Cadet J. L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci. 1992 May;12(5):1658–1667. doi: 10.1523/JNEUROSCI.12-05-01658.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Reynaud X., Dorey C. K. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci. 1994 Jul;35(8):3169–3177. [PubMed] [Google Scholar]
  31. Sacks L. M., Schaffer D. B., Anday E. K., Peckham G. J., Delivoria-Papadopoulos M. Retrolental fibroplasia and blood transfusion in very low-birth-weight infants. Pediatrics. 1981 Dec;68(6):770–774. [PubMed] [Google Scholar]
  32. Sakashita A., Epstein C. J., Carlson E., Koeffler H. P. Hematopoietic progenitor cells of transgenic mice with increased copper/zinc-superoxide dismutase activity are resistant to tumor necrosis factor. J Cell Physiol. 1994 Aug;160(2):233–238. doi: 10.1002/jcp.1041600204. [DOI] [PubMed] [Google Scholar]
  33. Scott M. D., Meshnick S. R., Eaton J. W. Superoxide dismutase-rich bacteria. Paradoxical increase in oxidant toxicity. J Biol Chem. 1987 Mar 15;262(8):3640–3645. [PubMed] [Google Scholar]
  34. Silverman W. A. Retinopathy of prematurity: oxygen dogma challenged. Arch Dis Child. 1982 Oct;57(10):731–733. doi: 10.1136/adc.57.10.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Smith L. E., Wesolowski E., McLellan A., Kostyk S. K., D'Amato R., Sullivan R., D'Amore P. A. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994 Jan;35(1):101–111. [PubMed] [Google Scholar]
  36. White C. W., Avraham K. B., Shanley P. F., Groner Y. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest. 1991 Jun;87(6):2162–2168. doi: 10.1172/JCI115249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yamashita H., Horie K., Yamamoto T., Katagiri H., Asano T., Hirano T., Nagano T., Oka Y. Superoxide dismutase in developing mouse retina. Jpn J Ophthalmol. 1994;38(2):148–161. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES